Welcome to ptTheragnostic

“Patient stratification for personalised radiotherapy”

That is what we at ptTheragnostic stand for. Healthcare has gotten more challenging and expensive throughout the years.
Finding the right treatment for the right patient is essential to continue the delivery of high-quality, individualised healthcare. ptTheragnostic has three core proprietary technology platforms to enable this:

  • MitoTx: genetic test to predict complication risk
  • PRODECIS: decision support for protontherapy
  • PREDICTapps: apps for tablets & smartphones

A prestigious NGI Pre-Seed Grant (EUR 250k) was obtained to help reach our goals.